Emergence of a high-plasticity cell state during lung cancer evolution Journal Article


Authors: Marjanovic, N. D.; Hofree, M.; Chan, J. E.; Canner, D.; Wu, K.; Trakala, M.; Hartmann, G. G.; Smith, O. C.; Kim, J. Y.; Evans, K. V.; Hudson, A.; Ashenberg, O.; Porter, C. B. M.; Bejnood, A.; Subramanian, A.; Pitter, K.; Yan, Y.; Delorey, T.; Phillips, D. R.; Shah, N.; Chaudhary, O.; Tsankov, A.; Hollmann, T.; Rekhtman, N.; Massion, P. P.; Poirier, J. T.; Mazutis, L.; Li, R.; Lee, J. H.; Amon, A.; Rudin, C. M.; Jacks, T.; Regev, A.; Tammela, T.
Article Title: Emergence of a high-plasticity cell state during lung cancer evolution
Abstract: Tumor evolution from a single cell into a malignant, heterogeneous tissue remains poorly understood. Here, we profile single-cell transcriptomes of genetically engineered mouse lung tumors at seven stages, from pre-neoplastic hyperplasia to adenocarcinoma. The diversity of transcriptional states increases over time and is reproducible across tumors and mice. Cancer cells progressively adopt alternate lineage identities, computationally predicted to be mediated through a common transitional, high-plasticity cell state (HPCS). Accordingly, HPCS cells prospectively isolated from mouse tumors and human patient-derived xenografts display high capacity for differentiation and proliferation. The HPCS program is associated with poor survival across human cancers and demonstrates chemoresistance in mice. Our study reveals a central principle underpinning intra-tumoral heterogeneity and motivates therapeutic targeting of the HPCS. Cellular states capable of promoting tumor progression and resisting therapies exist in heterogeneous tumors. Marjanovic et al. discover that a high-plasticity cell state common to mouse and human lung tumors drives cellular heterogeneity, is highly tumorigenic and drug resistant, and associates with poor patient prognosis. © 2020 Elsevier Inc.
Keywords: human cell; nonhuman; adenocarcinoma; cell proliferation; mouse; phenotype; animal experiment; animal model; lung cancer; cell differentiation; tumor xenograft; drug resistance; hyperplasia; transcriptome; endoderm; differentiation; tumor progression; plasticity; epithelial mesenchymal transition; tumor heterogeneity; cell plasticity; human; priority journal; article; chromatin state; tumor evolution; genetically engineered mouse strain; single-cell transcriptomics; cell state transition
Journal Title: Cancer Cell
Volume: 38
Issue: 2
ISSN: 1535-6108
Publisher: Cell Press  
Date Published: 2020-08-10
Start Page: 229
End Page: 246.e13
Language: English
DOI: 10.1016/j.ccell.2020.06.012
PUBMED: 32707077
PROVIDER: scopus
PMCID: PMC7745838
DOI/URL:
Notes: Article -- Export Date: 1 September 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Natasha Rekhtman
    424 Rekhtman
  2. Ken L Pitter
    53 Pitter
  3. Travis Jason Hollmann
    126 Hollmann
  4. Charles Rudin
    488 Rudin
  5. Nisargbhai Sanjaykumar Shah
    29 Shah
  6. John Thomas Poirier
    82 Poirier
  7. Tuomas Tammela
    23 Tammela
  8. Linas Mazutis
    34 Mazutis
  9. Jason Earl Chan
    28 Chan
  10. Katherine Wu
    5 Wu
  11. Anna Jane Hudson
    2 Hudson
  12. Yan Yan
    5 Yan
  13. Ruifang Li
    4 Li